First episode psychosis refers to the point at which a person experiences psychotic symptoms for the first time in their life. These symptoms can include hallucinations, delusions, disorganized thinking or major changes in behavior and functioning. FEP is not a single diagnosis. It can occur in schizophrenia-spectrum disorders, bipolar disorder, severe depression and several medical or substance-related conditions. Because early treatment is linked to better long-term outcomes, knowing how often FEP occurs is essential for planning specialized clinics, staffing early-intervention programs and directing public-health resources.

The researchers focus on U.S. claims data, enormous digital records generated when patients receive medical care and providers submit bills to insurers. These databases can include diagnostic codes, procedure codes, prescription information, dates of service and details about emergency, inpatient and outpatient treatment. Unlike traditional epidemiological surveys, claims datasets can cover millions of people and make it possible to study patterns across large geographic areas. Their scale, however, does not automatically make their estimates precise.

The central challenge is that a billing code is not the same as a clinical assessment. A code for psychosis may indicate a confirmed diagnosis, a suspected condition, a historical problem or a provisional label assigned during an emergency evaluation. Claims data also rarely contain the complete clinical narrative needed to determine whether symptoms truly represent a person’s first psychotic episode. A patient may have received care in another health system, paid out of pocket, changed insurers or carried an earlier diagnosis that is invisible in the database being studied.

Even the definition of “incidence” can vary. Some researchers count a first-ever psychosis-related diagnosis, while others count a first hospitalization, a first emergency-department visit or the first appearance of a relevant code after a period without documented care. These approaches can produce different numbers from the same underlying population. A study requiring a long “clean period”—a span of time with no previous psychosis-related claims—may reduce the likelihood of counting established cases as new, but it can also exclude people whose earlier treatment occurred outside the available records.

Age, sex, insurance type and geography can further influence the apparent rate of FEP. Young adults may be more likely to encounter emergency services, while people in rural areas may face limited access to psychiatrists and specialized programs. Differences in insurance coverage can determine which services generate observable claims. If researchers compare estimates without accounting for these factors, they may mistake variations in detection or access for genuine differences in disease occurrence.

The study’s call for standardization points toward a more consistent technical framework. Researchers need to specify which diagnostic codes qualify as psychosis, whether substance-induced and medically caused episodes are included, how long a person must remain free of prior claims to be considered a new case, and which healthcare settings are examined. They also need to define the population denominator—the number of people considered at risk—and explain how individuals with incomplete enrollment or interrupted insurance coverage are handled.

Validation is another crucial step. Claims-based algorithms should be compared with detailed chart reviews, clinical registries or structured assessments to determine how accurately they identify genuine FEP. Two statistical measures are especially important: sensitivity, or the ability to capture true cases, and positive predictive value, or the proportion of algorithm-identified cases that are confirmed after review. An algorithm with high sensitivity may find more possible cases but also produce more false positives; one with high specificity may miss people who received vague or inconsistent coding.

Standardized methods could make FEP estimates more comparable across states, insurers and research teams. That would help scientists detect real trends rather than methodological noise and could reveal whether early psychosis services are reaching the populations most in need. More reliable estimates could also strengthen efforts to investigate racial, socioeconomic and regional disparities, provided that claims data are interpreted carefully and not treated as a complete substitute for clinical information.

The message from the research is not that U.S. claims databases are unusable. On the contrary, their breadth makes them one of the most powerful tools available for studying mental-health care at scale. But their value depends on transparent definitions, validated case-finding methods and clear reporting standards. As health systems increasingly rely on administrative data and automated analytics, agreeing on what counts as a new case of psychosis may be the difference between a map that reveals a public-health crisis and one that merely reflects the quirks of the billing system.

Subject of Research: Estimating first episode psychosis incidence rates using U.S. claims data

Article Title: Estimating first episode psychosis (FEP) incidence rates using U.S. claims data: a need for standardization

Article References: Seiber, E.E., Sridhar, S., Hasenstab, K.A. et al. “Estimating first episode psychosis (FEP) incidence rates using U.S. claims data: a need for standardization.” Schizophrenia (2026). https://doi.org/10.1038/s41537-026-00793-4

Image Credits: AI Generated

DOI: 10.1038/s41537-026-00793-4

Keywords: First episode psychosis, FEP, incidence rates, U.S. claims data, schizophrenia, mental health, epidemiology, healthcare data, standardization

Dr. Kessler’s journey into psychiatric epidemiology started from an unlikely place: a Quaker village in Pennsylvania. Initially aspiring for a legal career as a first-generation college student, his academic curiosity was awakened by a mentor who recognized his analytical potential. Transitioning through sociology and criminology, Kessler’s empiricism matured with methodological rigor under the tutelage of experts at the University of Wisconsin and the New York State Psychiatric Institute. This eclectic academic foundation enabled him to approach psychiatric epidemiology with unique survey methodologies and an appreciation for longitudinal research designs—critical for disentangling the complex trajectories of mental disorders over time.

A turning point in his career emerged during his tenure at NBC, where Kessler confronted high-stakes, fast-paced survey research applied to television violence and child mental health. This exposure to real-world decision-making and rapid evaluation of data instilled in him an urgency to produce actionable knowledge. Unlike conventional academic settings, this environment demanded robust analytic strategies that could influence programming and advertising in near real-time, fueling Kessler’s commitment to methodological excellence coupled with pragmatic relevance.

At the University of Michigan, Kessler honed his expertise, benefiting from one of the world’s premier survey research institutions. Here, he directed an interdisciplinary psychiatric epidemiology training initiative and contributed to probing how socio-economic crises influenced mental health at the population level. His work expanded understanding of the interplay between social determinants and psychiatric morbidity, and he helped pioneer longitudinal designs that captured the evolution of mental health outcomes in changing social contexts. The collaborations formed during this period laid the groundwork for his most influential projects.

Among the most defining chapters was Kessler’s role in the MacArthur Foundation’s Research Network on Successful Midlife Development (MIDMAC), which pioneered the MIDUS (Midlife Development in the United States) project. This initiative integrated diverse data types—including cognitive testing, biomarker assays, and neuroscience sub-studies—to deliver an unprecedented, multidimensional portrait of mental and physical health in midlife adults. The insights gleaned continue to inform contemporary psychiatric and public health paradigms, influencing interventions targeting wellness and resilience.

Kessler’s seminal contribution, however, resides in the National Comorbidity Survey (NCS), which he led with a mission to chart the first nationally representative epidemiologic profile of DSM-defined disorders in the United States. Utilizing the Composite International Diagnostic Interview (CIDI), an instrument standardized for international use, the NCS unveiled the staggering prevalence of mental disorders, their early age of onset, and the profound societal burdens they impose. The survey’s longitudinal design and nuanced recall techniques allowed reconstruction of disorder trajectories, exposing critical windows for intervention and advocating for parity in mental health care — findings that reverberated globally.

Capitalizing on burgeoning interest and demand from international collaborators, Kessler spearheaded the World Mental Health (WMH) Survey Initiative, aggregating psychiatric epidemiological data from over 30 countries. This unprecedented consortium dismantled prior silos in mental health research, standardizing survey methodology across diverse cultural settings, and thus enabling direct cross-national comparisons of mental disorder prevalence and treatment gaps. The corpus of over 1,000 peer-reviewed publications and numerous monographs drawn from WMH data constitutes an encyclopedic resource shaping global policy discourse.

In pursuit of translational impact, Kessler’s recent work channels epidemiological insights into precision interventions. His SAFEGUARD program, deployed within the U.S. Army, exemplifies targeted suicide prevention strategies using algorithmic risk detection coupled with integrative experimental interventions. Parallelly, his collaboration through Menssano LLC advances scalable mental health solutions for university students, integrating pre-matriculation life skills training with digital therapeutic platforms designed to augment limited campus counseling resources. These hybrid approaches exemplify the future nexus between population-level surveillance and personalized care models.

Kessler envisions the development of continuous, hybrid mental health tracking systems that amalgamate probability-based panels with digital data collection, enabling near real-time evaluations of treatment needs and policy outcomes at the population scale. He advocates for embedding continuous quality improvement frameworks within academic institutions to monitor and enhance mental health outcomes, a model with broad applicability internationally amid rising youth psychological distress. These innovations promise to revolutionize the precision and efficiency of mental health service delivery.

Central to Kessler’s methodology is a commitment to rigor, transparency, and interdisciplinary collaboration. He underscores the necessity to question longstanding assumptions, employ optimal measurement strategies, and foster intellectual honesty about study limitations. Equally, he emphasizes the catalytic role of diverse expertise converging to solve complex problems, reflecting the multifaceted nature of psychiatric epidemiology. Importantly, mentorship and inclusivity remain bedrock principles, as Kessler seeks to democratize access to knowledge and networks, particularly for emergent scientists from underrepresented groups and institutions.

Kessler’s reflections on diversity, equity, and inclusion (DEI) in the sciences highlight the underappreciated dimensions of social class within DEI efforts. He argues for expanding the lens beyond racial and ethnic minorities to include socioeconomically disadvantaged populations who face structural educational and resource barriers. By advocating upstream interventions targeting early education disparities and promoting community college pathways as bridges within higher education, Kessler calls for structural reforms that address foundational inequities impacting scientific careers and research outcomes.

Beyond his scholarly persona, the interview reveals a multifaceted individual whose passion for antiques and sport illustrate a balanced life philosophy grounded in curiosity and connection. Rejecting notions of “perfect happiness,” Kessler aspires instead to sustained well-being anchored in purpose and relationships, shaped by his unique vantage point assessing human mental health. His personal narrative intertwines with his scientific odyssey, reminding readers that the pursuit of knowledge is inseparable from human experience.

As he contemplates the future, Kessler acknowledges uncertainties surrounding the politicization of science and research funding but remains optimistic about technological innovations poised to enhance psychosocial intervention quality. His enduring legacy arguably lies in establishing a global psychiatric epidemiologic infrastructure and mentoring a generation of investigators empowered to perpetuate this work worldwide. His aphorism—“Do the best you can, with the evidence you have, in the service of others”—encapsulates a career devoted to translating data into meaningful societal benefits.

The comprehensive interview, available open access in Genomic Psychiatry, offers an indispensable resource for scientists, clinicians, and policymakers aiming to harness advanced epidemiological methods to tackle mental health challenges on a global scale. Dr. Kessler’s career trajectory and current initiatives provide a blueprint for integrating rigorous science with compassionate application, exemplifying how epidemiological innovation can illuminate the path toward improved mental health for populations everywhere.

—

Subject of Research: People

Article Title: Ronald C. Kessler: Elucidating the population burden of mental disorders

News Publication Date: 3-Feb-2026

Web References:
https://doi.org/10.61373/gp026k.0021
https://url.genomicpress.com/2zwndyph

Image Credits: Ron Kessler, PhD

Keywords: psychiatric epidemiology, mental disorders, National Comorbidity Survey, World Mental Health Survey Initiative, mental health policy, suicide prevention, precision interventions, longitudinal survey, psychiatric diagnostics, mental health disparities, epidemiologic methods, global mental health